Manufacturer record
Norris Medicines Limited: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Norris Medicines Limited (Gujarat) were declared Not of Standard Quality between August 2023 and August 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Norris Medicines Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Trimax Expectorant (Terbutaline Sulphate with BromhexineHCl& Guaiphenesin), | 23009Mfg 2023-01 · Exp 2024-10 | Assay of Bromhexine Hydrochloride &Menthol.This sample is found to contain 0.118% w/v of Ethylene Glycol and this sample does not give positive test for Diethylene GlycolAssay | CDL KolkataCDSCO lab | Aug 2023 |
| CyproheptadineHCl with Tricholine Citrate Syrup (Sylpro Plus Syrup) | 33002Mfg 2023-05 · Exp 2025-04 | Assay of TricholineCitrate.This sample is found to contain Diethylene Glycol 0.243%w/v and Ethylene Glycol 0.171%w/vAssay | CDL KolkataCDSCO lab | Aug 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.